March 13, 2026 09:23 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Nobody will hire them': Supreme Court says menstrual leave would backfire, hurt women's careers | Rupee sinks to record low as West Asia conflict shakes Indian markets | ₹20 lakh crore wiped out: Indian markets post worst week in 4 years amid West Asia tensions | America’s flip-flop on Russian oil: How Washington sends conflicting signals to India | Big diplomatic win! Iran allows Indian oil tankers through the Strait of Hormuz | ‘It was over in the first hour’: Trump declares victory in Iran war, says ‘nothing left to target’ | Indian-origin shopkeepers face targeted attacks in Wembley; Somali men suspected | Iran pulls out of 2026 FIFA World Cup amid war with US-Israel | Supreme Court allows first-ever passive euthanasia for 32-year-old man in coma for 13 years | As Iran-US war disrupts global gas supply, India issues guidelines to manage shortages
Sputnik V
WIKIMEDIA COMMONS

Dr. Reddy’s Laboratories announces launch of Russia's Sputnik V vaccine in the Indian market, priced at Rs. 948

| @indiablooms | May 14, 2021, at 08:14 pm

Hyderabad: Dr. Reddy’s Laboratories Ltd on Friday announced that the first consignment of imported doses of the Russian Sputnik V vaccine that landed in India on May 1, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13.

As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad today on 14th May, 2021.

Further consignments of imported doses are expected over the upcoming months.Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing partners.

The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5% GST per dose, with the possibility of a lower price point when local supply begins.The Companyis working closely with its six manufacturing partners in India to fulfill regulatory requirements to ensure smooth and timely supply.

Dr. Reddy’s will work closely with stakeholders in the Government and private sector in India to ensure the widest possible reach of the Sputnik V vaccine as part of the national inoculation effort. This is a reaffirmation of the Company’s commitment to explore every avenue in the fight against the COVID-19 pandemic in India.

GV Prasad, Co-Chairman and Managing Director, said: “With the rising cases in India, vaccination is our most effective tool in our battle against COVID-19.Contributing to the vaccination drive in Indiais ourbiggest priorityright now to help Indians be healthy and safe.”

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.